- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07373444
Westlake Aging Cohort (WeAC)
Westlake Verouderingscohort
The Westlake Ageing Cohort (WeAC) is a longitudinal cohort study conducted in Hangzhou, Zhejiang Province, China. The investigators aim to enroll 2,800 participants aged 55 years and older for long-term follow-up. The population will include individuals with neurodegenerative diseases or those at the prodromal stage of cognitive impairment, as well as healthy middle-aged and older adults serving as controls. The investigators will collect their sociodemographic, dietary, lifestyle, clinical, and neuroimaging data, as well as biological samples.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
The investigators will recruit middle-aged and aged participants, including healthy controls and individuals with neurodegenerative disorders such as mild cognitive impairment (MCI), Alzheimer's disease (AD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB), etc. The aim of this study is to construct a longitudinal database that includes sociodemographic, lifestyle, clinical, neuroimaging, and multi-omics data. This database will be used to characterize the molecular signatures of neurodegenerative disorders. In addition, the investigators will identify biomarkers associated with neurodegenerative diseases. Furthermore, the investigators aim to uncover the mechanisms underlying the progression of mild cognitive impairment (MCI) and other neurodegenerative disorders.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Ju-Sheng Zheng, PhD
- Telefoonnummer: 86-0571-86915303
- E-mail: zhengjusheng@westlake.edu.cn
Studie Locaties
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Werving
- Hangzhou First People's Hospital
-
Contact:
- Ju-Sheng Zheng, PhD
- Telefoonnummer: 86-0571-86915303
- E-mail: zhengjusheng@westlake.edu.cn
-
Hangzhou, Zhejiang, China, 310058
- Werving
- Hangzhou Third People's Hospital
-
Contact:
- Peng Li, Master
-
Contact:
- Yu Chen, Master
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
All participants must be Chinese residents, regardless of their ethnicity.
Beschrijving
Inclusion Criteria:
- Age between 55 and 90 years (inclusive) at baseline.
- Availability of a companion capable of providing independent functional assessments and fluent in Chinese.
- Willingness and ability to regularly complete required surveys and physical examinations as per study protocol.
- MMSE scores were required to be 24-30 (inclusive) for healthy controls and MCI; and 20-24 (inclusive) for AD and DLB/PDD patients.
- Healthy controls: CDR = 0, memory box = 0. MCI: CDR = 0.5, memory box ≥ 0.5. AD: CDR = 0.5 or 1. The DLB/PDD meets the core features of diagnosis.
- Healthy controls exhibit no significant cognitive or functional decline. Patients with MCI have objective cognitive impairment not sufficient for an AD diagnosis. AD patients fulfill the NINCDS-ADRDA criteria. DLB/PDD patients meet their respective international consensus diagnostic criteria. Other neurodegenerative diseases meet the diagnostic criteria.
Exclusion Criteria:
- Participants with major medical or neuropsychiatric conditions unrelated to the study purposes were excluded. These included, but were not limited to, psychiatric disorders, cancer, infectious diseases, structural brain abnormalities, and epilepsy.
- Current use of psychoactive medications or any other drugs that may affect the study.
- Participants with cardiac pacemakers, artificial heart valves, or metallic implants in the eyes, skin, or any other part of the body.
- Participants with any other diseases that may affect the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cognitive function
Tijdsspanne: 48 months
|
Cognitive function will be evaluated using the Mini-Mental State Examination (MMSE, score range: 0-30, with higher scores indicating better cognitive function) and clinical diagnosis provided by physicians. |
48 months
|
|
Gut microbiome
Tijdsspanne: 48 months
|
The gut microbiome will be profiled by metagenomic sequencing or ITS rRNA sequencing. In addition, fecal microbiota will be cultured, isolated, and identified. |
48 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Brain magnetic resonance imaging
Tijdsspanne: 48 months
|
Use brain magnetic resonance imaging (MRI) to measure the brain structure and function of participants. |
48 months
|
|
Positron emission tomography
Tijdsspanne: 48 months
|
Assess the brain function and neurological disorders by positron emission tomography (PET). |
48 months
|
|
Brain images relevant inspections
Tijdsspanne: 48 months
|
Other brain image relevant inspections required for study to measure brain structure and function of participants. |
48 months
|
|
Electroencephalogram
Tijdsspanne: 48 months
|
Electroencephalogram (EEG) monitors the electrical activity of the brain. And further measure based on coupled EEG/MEG and eye-tracking. |
48 months
|
|
Blood biochemical parameters
Tijdsspanne: 48 months
|
Blood biochemical parameters, including glucose and lipids, will be analyzed using an automated biochemical analyzer. |
48 months
|
|
Serum inflammatory factors
Tijdsspanne: 48 months
|
Detect and assess serum inflammatory factors such as IL-1β, IL-6, and IL-12, in serum from participants. |
48 months
|
|
Health and behavior monitoring
Tijdsspanne: 48 months
|
Use fitness trackers to record the physiological and behavioral data of participants. |
48 months
|
|
Sleep data measurement
Tijdsspanne: 48 months
|
Use the polysomnography (PSG) to record the sleep data of participants to evaluate the sleep quality. |
48 months
|
|
Continuous glucose monitoring
Tijdsspanne: 48 months
|
Use the continuous glucose monitoring (CGM) for dynamic blood glucose recording to determine the glycemic control of participants. |
48 months
|
|
Environmental measurement
Tijdsspanne: 48 months
|
Use the environmental monitoring device to measure various exposure factors in the participants' living environment. |
48 months
|
|
Multi-omics data
Tijdsspanne: 48 months
|
Multi omics results of detecting biological samples such as plasma, peripheral blood mononuclear cells (PBMCs), urine, feces, saliva, etc. |
48 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Ju-Sheng Zheng, PhD, Westlake University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 20251023ZJS001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .